-
Recent studies by a team of geneticists from city-based Centre for Cellular and Molecular Biology (CCMB) has indicated ‘striking novel regulatory functions of Y chromosome DNA’.
-
Hyderabad: The Centre for Cellular and Molecular Biology (CCMB) is organising OMICS-2021, the 13th annual meeting of Proteomics Society of India (PSI) from October 20 to 23. The OMICS-2021 virtual conference, which is being organised by CCMB, PSI and CCMB Foundation with the theme ‘Omics in Redefining Biology’, will feature widespread discussions on cutting-edge developments […]
-
As part of the study, the researchers analysed DNA of 110 individuals from Roman Catholic community of Goa, Kumta and Mangalore.
-
No one group or individual can take credit for CSIR’s contributions in fighting Covid-19 and the entire credit goes to CSIR as an organisation, said Dr Shekhar C Mande, DG CSIR
-
Hyderabad: A latest study by researchers from Hyderabad-based Centre for Cellular and Molecular Biology (CCMB), published in peer-reviewed journal Science Advances, has thrown a new light on possible ways to develop better therapeutics related to cholesterol. In the study, CCMB researchers report a sensor region on human serotonin1A receptor that can detect cholesterol. They looked […]
-
Queen Ketevan is universally venerated by the Georgians for her courageous stand against the demand for forcible conversion.
-
Naidu also called for closer collaboration between zoos and research institutions that will help in studying diseases in wildlife and preserve genetic material of animals.
-
The special guidelines from LaCONES-CCMB have been released after Covid-19 was reported among zoo animals in the country
-
The consortium led by CCMB includes NCBS-TIFR, InStem-DBT and NIMHANS in Bengaluru, CSIR-IGIB in New Delhi, Pune Knowledge Cluster, IISER-Pune and CSIR-NCL in Pune
-
The multidisciplinary research unit at BHU collected about 130 samples for sequencing from Varanasi and areas around the city in April
-
Meril’s Extraction-free Dry Swab Kit can be used to isolate the viral RNA from dry swab samples and then can be directly used for RT-PCR
-
The CCMB’s technique eliminates need for expensive cold chain network
-
The drug can be added as a supplement or adjunct to the existing treatment protocols to treat moderate to severe Covid patients
-
The latest therapy with links to the city is the glucose molecule 2-DG and its anti-Covid-19 therapeutic application that was given a green signal by Indian drug regulatory authorities
-
The dry swab-based direct RT-PCR method of Covid-19 testing developed by CCMB and approved by ICMR can now be adopted in testing labs of the country.
-
The N440K can generate about ten times more virus particles than the A2a prototype, the strain which is in circulation worldwide
-
Covid-19 drug candidate has been developed by VINS Bioproducts in collaboration with Centre for Cellular and Molecular Biology and University of Hyderabad
-
Double mutant strains found in 4-5% of samples in Telangana
-
We now have emerging evidence that N440K is spreading a lot more in southern states, says CCMB
-
RICH, an initiative by the Telangana government, has invited applications for their start-up accelerator programme from promising start-ups